期刊文献+

肝炎平对肝纤维化肝组织中去甲肾上腺素和多巴胺的影响 被引量:5

The effect of Ganyanping on Norepinephrine and Dopamine in liver tissue of fibrosis
下载PDF
导出
摘要 目的:探讨肝炎平在四氯化碳(CCl4)诱导的肝纤维化模型中对肝脏中去甲肾上腺素(NE)和多巴胺(DA)的影响及其抗肝纤维化的可能机制。方法:CCl4诱导大鼠慢性肝纤维化模型。随机分为正常组、肝纤维化模型组和肝炎平治疗组。用高效液相色谱-电化学(HPLC-ECD)法检测肝组织中NE和DA水平。结果:肝炎平组和模型组大鼠肝组织内NE含量明显低于正常组(P<0·01),且模型组NE含量低于肝炎平组(P<0·05);而DA在3组中的含量差异无显著性意义(P>0·05)。结论:肝炎平可增加肝纤维化肝组织中NE的含量,可能主要通过调节肝纤维化大鼠肝脏中的NE含量而达到抗肝纤维化的作用。 Objective: To investigate the effect fo Ganyanping (GYP) on Norepinephrine (NE) and Dopamine (DA) and the possible mechanism resisting hepatic fibrosis induced by carbon tetrachloride (CCI4). Methods: The 40 rats were randomly diveded into control group, model group and GYP-treated group. The NE and DA concentrations in liver tissue were determined with high performanec liquid chromatography-electrochemical detector (HPLC-ECD). Results: The levels of NE in model and GYP-treated group were obviously less than in control group (P〈0.01), and NE in model group was less than in GYP-treated group (P〈0.05) ; while DA was similar in the three groups (P〉0.05). Conclusion: GYP could increase the NE concentrations in liver tissue of fibrosis, and achieved to inhibit the hepatic fibrosis mainly by regulating the levels of NE in rats with hepatic fibrosis.
出处 《中西医结合肝病杂志》 CAS 2006年第2期84-86,T0001,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 国家自然科学基金课题专项基金(No.30440088)
关键词 肝炎平/药效学 肝纤维化 去甲肾上腺素 多巴胺 高效液相色谱-电化学 大鼠 Ganyanping/pharmacodynarnics hepatic fibrosis norepinephrine dopamine high performance liquid chromatography-electrochemical detecter rat
  • 相关文献

参考文献10

  • 1Tang WX, Zi-Li Dan, Hong-Mei Yan, et al. Experimental study of effect of Ganyanping on fibrosis in rat liver. World Joural of Gastroenterology, 2003, 9 (6): 1292-1295
  • 2唐望先,虞涤霞,但自力,杜荔菁,张文英,李绍白.肝炎平对大鼠慢性肝损害胶原纤维作用的实验研究[J].胃肠病学和肝病学杂志,1998,7(2):167-169. 被引量:7
  • 3Trim N, Morgans, Evans M, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor P75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Phthol, 2000, 156(4): 1235-1243.
  • 4Dubuisson L, Desmouliere A, Deeourt B, et od. Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatolcgy, 2002,35 (2): 325-331.
  • 5唐望先,金琦,舒柏华,艾莉,袁顺玉.肝炎平抗兔血吸虫肝纤维化的实验研究[J].华中科技大学学报(医学版),2005,34(4):454-457. 被引量:1
  • 6阎玉矿,杨镇,戴植本.肝硬变大鼠肝内去甲肾上腺素能神经的荧光组织化学分析[J].当代医师,1996,1(1):26-27. 被引量:2
  • 7Schwetz BA and Plaa GL. Catecholamine poteniation of carbon tetra-chloride -induced hepatotoxieity in mice. Toxieol Appl Pharmaeol,1969, 14 (3): 495-509.
  • 8Oben JA, Roskams T, Yang S, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut, 2004, 53 (3): 438-445.
  • 9Oben JA, Yang S, Lin H, et al. Acetylcholine promotes the proliferation and collagen gene expression of myofibroblastic hepatic stellate cells. Biochem Biophys Res Commun, 2003, 300 (1) : 172-177.
  • 10Oben JA, Yang S, Lin H, et al. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofi-broblastic stellate cells. Biochem Biophys Res Commun, 2003, 302(4) : 685-690.

二级参考文献9

共引文献7

同被引文献40

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部